Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07872020
ABSTRACT:
The present invention provides crystalline 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro -4H-pyrrolo[1,2-b]pyrazole monohydrate.
REFERENCES:
patent: WO 02/094833 (2002-11-01), None
patent: WO 2004/048382 (2004-06-01), None
patent: WO 2004/048383 (2004-06-01), None
IMPCA methanol reference specifications.
Cornet Jean
Eli Lilly and Company
Fetterolf Brandon J
Hostettler Danica
McGraw Elizabeth A.
LandOfFree
TGF-β inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TGF-β inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TGF-β inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742142